Zantac Esophageal Cancer

Zantac and other ranitidine products were recently completely removed from the market by the Food and Drug Administration (FDA) due to a contaminant found within. That contaminant is NDMA (N-Nitrosodimethylamine), which the World Health Organization (WHO), the Environmental Protection Agency (EPA), and other national and international health organizations all consider a probable carcinogen or cancer-causing agent. One closely associated cancer is esophageal cancer. If you’ve developed esophageal cancer after being a regular Zantac user, consult with an experienced drug injury attorney today.

Zantac

Zantac (ranitidine) is a popular and lucrative medication used for the treatment of all the following:

• Heartburn
• Gastroesophageal reflux disease (GERD)
• Ulcers
• Similar health conditions

In Spring of 2019, Valisure, an online drugstore that is committed to the safety of the drugs it sells, discovered in the course of its routine testing for quality assurance and consistency that Zantac and other ranitidine products contained unacceptable levels of NDMA. Upon this finding, several manufacturers withdrew their ranitidine products, and several large drugstore chains dropped the medications altogether. The FDA did not follow suit, however, for several more months.

You Need an Experienced Drug Injury Attorney on Your Side

If you’ve regularly taken Zantac to help control your heartburn or other gastrointestinal condition and have since developed esophageal cancer, there may be a connection that you should not ignore. You took Zantac in good faith that it would help restore your health – and not leave you more ill than you were to begin with. Large drug companies should be held strictly accountable for any unreasonable health risks their medications pose, and a formidable drug injury attorney can help you with that.